Latest News and Press Releases
Want to stay updated on the latest news?
-
New York, New York, March 30, 2026 (GLOBE NEWSWIRE) -- Kaltura, the Agentic Digital Experience company, today announced a new strategic partnership with Descript, an AI-powered audio and video...
-
First mass-produced Lotus equipped with X-Hybrid Architecture, delivering full-scenario high performanceIconic Lotus handling recreated through an advanced lightweight, aerodynamics, and...
-
Reports $46.8M Revenue for 2025 materially ahead of market expectations Exits 2025 at $232M ARR1 with $19.4M December MRR1 Contracted Revenue1 Underpins 2026 Growth Trajectory FY 2026 revenue...
-
Confirmed partial response at 220 mg indicates anti-tumor activity of APR-1051 in biomarker-defined cancersEarly clinical data suggest the potential of APR-1051 as a best-in-class WEE1...
-
HTVRONT Launches D2 DTF Printer to Simplify Small Business Production with a More “Worry-Free” Start
HTVRONT launches the D2 DTF printer with reduced maintenance, simplified workflow, and stable output, helping small businesses start and scale production.
-
HOUSTON, March 30, 2026 (GLOBE NEWSWIRE) -- Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) (collectively, "Plains") today provided an update on the expected...
-
ROCKAWAY, N.J., March 30, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the issuance of two new U.S....
-
UroGen announces that the pivotal ENVISION 24 mo. Duration of Response date has been published online in The Journal of Urology.
-
CHICAGO, March 30, 2026 (GLOBE NEWSWIRE) -- CCC Intelligent Solutions Inc. (CCC), a leading cloud platform provider powering the insurance economy, today announced that All Clear Diagnostics and...
-
Teva’s biosimilar, PONLIMSI™, is now FDA-approved across all indications of the reference product, Prolia® (denosumab), to treat a variety of debilitating bone conditions.Teva’s proposed biosimilar...